179 related articles for article (PubMed ID: 29083981)
1. Genomic Hallmarks of Thyroid Neoplasia.
Giordano TJ
Annu Rev Pathol; 2018 Jan; 13():141-162. PubMed ID: 29083981
[TBL] [Abstract][Full Text] [Related]
2. ENDOCRINE TUMOURS: Advances in the molecular pathogenesis of thyroid cancer: lessons from the cancer genome.
Riesco-Eizaguirre G; Santisteban P
Eur J Endocrinol; 2016 Nov; 175(5):R203-17. PubMed ID: 27666535
[TBL] [Abstract][Full Text] [Related]
3. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
4. The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy.
Kasaian K; Wiseman SM; Walker BA; Schein JE; Zhao Y; Hirst M; Moore RA; Mungall AJ; Marra MA; Jones SJ
BMC Cancer; 2015 Dec; 15():984. PubMed ID: 26680454
[TBL] [Abstract][Full Text] [Related]
5. Follicular cell thyroid neoplasia: insights from genomics and The Cancer Genome Atlas research network.
Giordano TJ
Curr Opin Oncol; 2016 Jan; 28(1):1-4. PubMed ID: 26569424
[TBL] [Abstract][Full Text] [Related]
6. Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas.
Pallante P; Visone R; Croce CM; Fusco A
Endocr Relat Cancer; 2010 Mar; 17(1):F91-104. PubMed ID: 19942715
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of somatic genomic imbalances in thyroid carcinomas of follicular origin by CGH-based approaches.
Baldan F; Mio C; Allegri L; Passon N; Lepore SM; Russo D; Damante G
Minerva Endocrinol; 2018 Sep; 43(3):285-293. PubMed ID: 28880059
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-146b: A Novel Biomarker and Therapeutic Target for Human Papillary Thyroid Cancer.
Chou CK; Liu RT; Kang HY
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28294980
[TBL] [Abstract][Full Text] [Related]
9. Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of
Ibrahimpasic T; Xu B; Landa I; Dogan S; Middha S; Seshan V; Deraje S; Carlson DL; Migliacci J; Knauf JA; Untch B; Berger MF; Morris L; Tuttle RM; Chan T; Fagin JA; Ghossein R; Ganly I
Clin Cancer Res; 2017 Oct; 23(19):5970-5980. PubMed ID: 28634282
[No Abstract] [Full Text] [Related]
10. A general method to derive robust organ-specific gene expression-based differentiation indices: application to thyroid cancer diagnostic.
Tomás G; Tarabichi M; Gacquer D; Hébrant A; Dom G; Dumont JE; Keutgen X; Fahey TJ; Maenhaut C; Detours V
Oncogene; 2012 Oct; 31(41):4490-8. PubMed ID: 22266856
[TBL] [Abstract][Full Text] [Related]
11. [The role of genetic factors in the pathogenesis of thyroid neoplasms].
Ferenc T; Maciaszczyk K; Gesing A; Lewiński A
Postepy Hig Med Dosw; 1997; 51(4):367-84. PubMed ID: 9446100
[TBL] [Abstract][Full Text] [Related]
12. Pathology and genetics of thyroid carcinoma.
DeLellis RA
J Surg Oncol; 2006 Dec; 94(8):662-9. PubMed ID: 17131411
[TBL] [Abstract][Full Text] [Related]
13. Thyroid cancers of follicular origin in a genomic light: in-depth overview of common and unique molecular marker candidates.
Pstrąg N; Ziemnicka K; Bluyssen H; Wesoły J
Mol Cancer; 2018 Aug; 17(1):116. PubMed ID: 30089490
[TBL] [Abstract][Full Text] [Related]
14. Fetal cell carcinogenesis of the thyroid: a hypothesis for better understanding of gene expression profile and genomic alternation in thyroid carcinoma.
Takano T
Endocr J; 2004 Dec; 51(6):509-15. PubMed ID: 15644567
[TBL] [Abstract][Full Text] [Related]
15. Genetic considerations in thyroid cancer.
Patel KN; Singh B
Cancer Control; 2006 Apr; 13(2):111-8. PubMed ID: 16735985
[TBL] [Abstract][Full Text] [Related]
16. BRAF mutations in an Italian cohort of thyroid cancers.
Fugazzola L; Mannavola D; Cirello V; Vannucchi G; Muzza M; Vicentini L; Beck-Peccoz P
Clin Endocrinol (Oxf); 2004 Aug; 61(2):239-43. PubMed ID: 15272920
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal aberrations in thyroid follicular-cell neoplasia: in the search of novel oncogenes and tumour suppressor genes.
Zitzelsberger H; Thomas G; Unger K
Mol Cell Endocrinol; 2010 May; 321(1):57-66. PubMed ID: 19961897
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of a hobnail pattern in papillary, poorly differentiated, and anaplastic thyroid carcinoma: a possible manifestation of high-grade transformation.
Amacher AM; Goyal B; Lewis JS; El-Mofty SK; Chernock RD
Am J Surg Pathol; 2015 Feb; 39(2):260-5. PubMed ID: 25321328
[TBL] [Abstract][Full Text] [Related]
19. Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma.
Wang HM; Huang YW; Huang JS; Wang CH; Kok VC; Hung CM; Chen HM; Tzen CY
Ann Surg Oncol; 2007 Oct; 14(10):3011-8. PubMed ID: 17638058
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma.
Rossing M; Borup R; Henao R; Winther O; Vikesaa J; Niazi O; Godballe C; Krogdahl A; Glud M; Hjort-Sørensen C; Kiss K; Bennedbæk FN; Nielsen FC
J Mol Endocrinol; 2012 Feb; 48(1):11-23. PubMed ID: 22049245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
